These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26356815)

  • 1. HOXA13 is a potential GBM diagnostic marker and promotes glioma invasion by activating the Wnt and TGF-β pathways.
    Duan R; Han L; Wang Q; Wei J; Chen L; Zhang J; Kang C; Wang L
    Oncotarget; 2015 Sep; 6(29):27778-93. PubMed ID: 26356815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-215, an activator of the CTNNBIP1/β-catenin pathway, is a marker of poor prognosis in human glioma.
    Tong YQ; Liu B; Zheng HY; Gu J; Liu H; Li F; Tan BH; Hartman M; Song C; Li Y
    Oncotarget; 2015 Sep; 6(28):25024-33. PubMed ID: 26317904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-β and epithelial-mesenchymal transition are associated with pulmonary metastasis in adenoid cystic carcinoma.
    Dong L; Ge XY; Wang YX; Yang LQ; Li SL; Yu GY; Gao Y; Fu J
    Oral Oncol; 2013 Nov; 49(11):1051-8. PubMed ID: 23962790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Let-7a suppresses glioma cell proliferation and invasion through TGF-β/Smad3 signaling pathway by targeting HMGA2.
    Li Y; Zhang X; Chen D; Ma C
    Tumour Biol; 2016 Jun; 37(6):8107-19. PubMed ID: 26715270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astragaloside IV suppresses transforming growth factor-β1-induced epithelial-mesenchymal transition through inhibition of Wnt/β-catenin pathway in glioma U251 cells.
    Han J; Shen X; Zhang Y; Wang S; Zhou L
    Biosci Biotechnol Biochem; 2020 Jul; 84(7):1345-1352. PubMed ID: 32154763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-β promotes glioma cell growth via activating Nodal expression through Smad and ERK1/2 pathways.
    Sun J; Liu SZ; Lin Y; Cao XP; Liu JM
    Biochem Biophys Res Commun; 2014 Jan; 443(3):1066-72. PubMed ID: 24370825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpressed P75CUX1 promotes EMT in glioma infiltration by activating β-catenin.
    Xu A; Wang X; Luo J; Zhou M; Yi R; Huang T; Lin J; Wu Z; Xie C; Ding S; Zeng Y; Song Y
    Cell Death Dis; 2021 Feb; 12(2):157. PubMed ID: 33542188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homeobox-A13 acts as a functional prognostic and diagnostic biomarker via regulating P53 and Wnt signaling pathways in lung cancer.
    Wang Y; He B; Dong Y; He GJ; Qi XW; Li Y; Yang YF; Rao Y; Cen ZS; Han F; Ding J; Li JJ
    Cancer Biomark; 2021; 31(3):239-254. PubMed ID: 33896818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/β-catenin pathway and predicts poor survival of glioma patients.
    Zhang J; Cai H; Sun L; Zhan P; Chen M; Zhang F; Ran Y; Wan J
    J Exp Clin Cancer Res; 2018 Sep; 37(1):225. PubMed ID: 30208924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HOXA13 promotes colon cancer progression through β-catenin-dependent WNT pathway.
    Gu Y; Gu J; Shen K; Zhou H; Hao J; Li F; Yu H; Chen Y; Li J; Li Y; Liang H; Dong Y
    Exp Cell Res; 2020 Oct; 395(2):112238. PubMed ID: 32822724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZNF326 promotes malignant phenotype of glioma by up-regulating HDAC7 expression and activating Wnt pathway.
    Yu X; Wang M; Wu J; Han Q; Zhang X
    J Exp Clin Cancer Res; 2019 Jan; 38(1):40. PubMed ID: 30691485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KITENIN promotes glioma invasiveness and progression, associated with the induction of EMT and stemness markers.
    Lee KH; Ahn EJ; Oh SJ; Kim O; Joo YE; Bae JA; Yoon S; Ryu HH; Jung S; Kim KK; Lee JH; Moon KS
    Oncotarget; 2015 Feb; 6(5):3240-53. PubMed ID: 25605251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nuclear transporter importin-11 regulates the Wnt/β-catenin pathway and acts as a tumor promoter in glioma.
    Ni H; Ji D; Li J; Zhao Z; Zuo J
    Int J Biol Macromol; 2021 Apr; 176():145-156. PubMed ID: 33571591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
    Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
    Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prosaposin is a biomarker of mesenchymal glioblastoma and regulates mesenchymal transition through the TGF-β1/Smad signaling pathway.
    Jiang Y; Zhou J; Hou D; Luo P; Gao H; Ma Y; Chen YS; Li L; Zou D; Zhang H; Zhang Y; Jing Z
    J Pathol; 2019 Sep; 249(1):26-38. PubMed ID: 30953361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smad2/3-Regulated Expression of DLX2 Is Associated with Radiation-Induced Epithelial-Mesenchymal Transition and Radioresistance of A549 and MDA-MB-231 Human Cancer Cell Lines.
    Choi YJ; Baek GY; Park HR; Jo SK; Jung U
    PLoS One; 2016; 11(1):e0147343. PubMed ID: 26799321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpressed homeobox B9 regulates oncogenic activities by transforming growth factor-β1 in gliomas.
    Fang L; Xu Y; Zou L
    Biochem Biophys Res Commun; 2014 Mar; 446(1):272-9. PubMed ID: 24582746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ring finger protein 125, as a potential highly aggressive and unfavorable prognostic biomarker, promotes the invasion and metastasis of human gallbladder cancers via activating the TGF- β1-SMAD3-ID1 signaling pathway.
    Liu ZY; Cao J; Zhang JT; Xu GL; Li XP; Wang FT; Ansari KH; Mohamed H; Fan YZ
    Oncotarget; 2017 Jul; 8(30):49897-49914. PubMed ID: 28611292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of transcriptional coactivator TAZ in gliomas.
    Li W; Dong S; Wei W; Wang G; Zhang A; Pu P; Jia Z
    Oncotarget; 2016 Dec; 7(50):82686-82699. PubMed ID: 27764783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-talk between TGF-β/Smad pathway and Wnt/β-catenin pathway in pathological scar formation.
    Sun Q; Guo S; Wang CC; Sun X; Wang D; Xu N; Jin SF; Li KZ
    Int J Clin Exp Pathol; 2015; 8(6):7631-9. PubMed ID: 26261683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.